Therapeutic choices in rifampicin-resistant tuberculosis

Lancet Infect Dis. 2016 Nov;16(11):1220-1221. doi: 10.1016/S1473-3099(16)30399-1.

Authors

Shashank Ganatra¹, Zarir Udwadia², Camilla Rodrigues²

Affiliations

¹ Hinduja National Hospital and Medical Research Centre, Mahim, Mumbai 400016, India. Electronic address: [email protected].
² Hinduja National Hospital and Medical Research Centre, Mahim, Mumbai 400016, India.

PMID: 27788974
DOI: 10.1016/S1473-3099(16)30399-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents
Drug Resistance, Bacterial / drug effects
Humans
Microbial Sensitivity Tests
Mycobacterium tuberculosis / drug effects
Rifampin*
Tuberculosis, Multidrug-Resistant*

Substances

Antitubercular Agents
Rifampin